Thursday, May 29, 2008

Risperdal goes generic soon


Drugmakers’ Me-Too Medicines Face Tough Customers:Big Pharma’s pitches for new and improved versions of old drugs aren’t working the magic they used to.

Posted by Scott Hensley




Johnson & Johnson still hopes for better sales of Invega (AP)
New York psychiatrist Jeffrey Lieberman has heard Johnson & Johnson’s spiel for schizophrenia medicine Invega, a derivative of the company’s blockbuster Risperdal, that was launched last year. And he’s not buying it.

Invega is “basically a me-too drug, and the company hasn’t done the studies that would be required to really distinguish it,” Lieberman, chairman of the psychiatry department at Columbia University’s medical school told Peter Loftus of Dow Jones Newswires.

Dan Carlat, a psychiatrist and a tough critic of Invega, wrote that J&J’s “marketing team apparently missed the fact that the word in the English language that sounds most like “Invega” is “inveigle,” meaning “to entice, lure, or ensnare by flattery or artful talk or inducements.’ ” He asked doctors: “Will you be doing your patients a favor by taking the plunge? Or will you simply be giving them the same wine in a fancier bottle?”

The psychiatrists’ skepticism, Dow Jones reports, is shared broadly by health insurers and points to a rising challenge for drug makers: a tougher market for follow-on drugs. Cheap generics abound to treat a broad assortment of illnesses these days. What’s the point, the critics ask, of paying more for drugs that are at best only slight improvements over tried and true medicines available at bargain prices?

The tougher landscape is bad news for J&J. Risperdal goes generic in the U.S. next month. For the four months ending in April, U.S. sales of Invega were $85 million compared with $810 million for the oral form of Risperdal, according to data from Wolters Kluwer Health.


Following this article in the Wall Street Journal is a lively discussion between (what I call) realists and what I can only assume are investors.

3 Comments:

At 6:39 PM, Blogger Mark p.s. said...

What happened on friday? I hope you are well.

 
At 5:39 AM, Blogger liberated psych said...

Thanks for asking Mark. It went well but I am suspicious of the medical people and was frankly worried. In November I was hauled to Mayo in Rochester and after a week they said I could go home, but the evening before I was to leave, they brought a pill in an envelope (I was on risperdal which is really common and never came in an envelope before) and then they kept me another week and whereas just one doctor and a pharmacist visited me before, now there were several every time. I was also put in a room with cameras but I was absolutely not a suicide risk unlike several with bound wrists. Of course, if you tell anyone of your suspicions, they roll their eyes and say you are paranoid.

 
At 9:14 AM, Blogger Gianna said...

Hi...Hope you're feeling better...

I have been writing about rispderdal going generic and it's totally unclear to me at this point when it's actually going to happen.

we were told June at some point in the past, but a month or so ago I did some research and found that the earliest it might be generic is in 2011...

but I'm confused...

If you want to see what I found out and see what you think go to my blog and in the top right corner type in "Risperdal generic"

That will take you to the post where I got my latest info, but frankly I'm not sure it's reliable...but whenever I do google searches I don't find anything else any more clear than that...

what do you think?

 

Post a Comment

Links to this post:

Create a Link

<< Home